Evaluation of major national dementia policies and health‐care system preparedness for early medical action and implementation-Reference-Cited by-全球学者库

Evaluation of major national dementia policies and health‐care system preparedness for early medical action and implementation

Published:2022-03-16 Issue:10 Volume:18 Page:1993-2002
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Hampel Harald¹^ORCID,Vergallo Andrea¹,Iwatsubo Takeshi²,Cho Min¹,Kurokawa Kiyoshi³,Wang Huali⁴,Kurzman H. Ricky¹,Chen Christopher⁵

Affiliation:

1. Neurology Business Group Eisai Inc. Nutley New Jersey USA

2. University of Tokyo Tokyo Japan

3. National Graduate Institute for Policy Studies Chairman, Health and Global Policy Institute Tokyo Japan

4. Peking University Institute of Mental Health (Sixth Hospital) Beijing China

5. Department of Pharmacology, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12655

Reference73 articles.

1. Dementia. World Health Organization. September 2 2021. Accessed January 11 2022.https://www.who.int/news‐room/fact‐sheets/detail/dementia

2. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

3. New blood test to identify people at risk of developing Alzheimer’s symptoms will be used in clinical trial aiming to prevent memory loss. PRNewswire. November 11 2021. Accessed January 10 2022.https://www.prnewswire.com/news‐releases/new‐blood‐test‐to‐identify‐people‐at‐risk‐of‐developing‐alzheimers‐symptoms‐will‐be‐used‐in‐clinical‐trial‐aiming‐to‐prevent‐memory‐loss‐301422214.html

4. The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validity and Reliability Study of Online Cognitive Tracking Software (BEYNEX);Journal of Alzheimer's Disease Reports;2024-02-06

2. Changes in dementia treatment patterns associated with changes in the National Policy in South Korea among patients with newly diagnosed Alzheimer’s disease between 2011 and 2017: results from the multicenter, retrospective CAPTAIN study;BMC Public Health;2024-01-12

3. Association between Support after Dementia Diagnosis and Subsequent Decrease in Social Participation;Annals of Geriatric Medicine and Research;2023-09-30

4. Addressing gaps in primary care diagnosis of cognitive impairment via a telephone‐based nurse consultation;Journal of the American Geriatrics Society;2023-01-27

5. A policy overview of Japan's progress on dementia care in a superaged society and future challenges;Global Health & Medicine;2023